Skip to main content Help with accessibility Skip to main navigation

Abatacept

Indication

Juvenile Idiopathic Arthritis (JIA) in Adult Patients  
Red

Brand:

Orencia ®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Musculoskeletal system

Background

Treatment with Abatacept for adult patients with JIA is recommended in Lancashire and South Cumbria in the following circumstances:-

  • Young people with JIA currently being treated with one of the agents and transferring over from adolescent to adult services
  • Patients with JIA whose disease becomes active during adult life
  • Patients with JIA requiring a biologic agent to be reinstated (e.g. after a period of remission or pregnancy)

In the above circumstances treatment is only recommended if the following criteria are met:

1. Treatment was in line with NICE TA238 or TA373 before transfer to adult services OR is in line with NICE TA238 or TA373 (with the exception of any age restrictions) for newly treated patients. For continuation into adulthood, if treatment was not in line with a NICE TA, the patient may continue to receive treatment until the prescribing clinician feels this may be stopped.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Decisions of Lancashire local decision making groups

Pending
Pending
Red
Pending
Red
Red
Red
Pending
What do the colours mean?

Last Updated: 01 - Jun - 2015